Clinical Trial

Hemodynamic Venous Congestion Ultrasound (VExUS) by ICU Nurses in Sepsis Patients.

Study acronym: VEXIVAN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Sepsis is a serious condition where the body's immune response to infection overreacts, leading to organ damage and death. Venous congestion, a buildup of blood in the veins, can occur in sepsis and contribute to organ injury. VExUS (Venous Excess Ultrasound Score) is an ultrasound method that can detect congestion early. This study examines whether ICU nurses, after training, can perform VExUS reliably, explores their experiences, and investigates links between VExUS findings and clinical outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-09.
Trial Details
NCT Number NCT07406750
Lead Sponsor Region Örebro County
Collaborators: Örebro University, Sweden, Region Östergötland, Dalarna County Council, Sweden
Conditions Sepsis, Sepsis and Septic Shock, Sepsis at Intensive Care Unit, Intensive Care Nurses
Enrollment 46 participants
Start Date 2026-04-01
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-18